Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint

Eur Respir J. 2024 Jan 25;63(1):2301959. doi: 10.1183/13993003.01959-2023. Print 2024 Jan.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aminophenols*
  • Benzodioxoles*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / drug therapy
  • Cystic Fibrosis* / genetics
  • Humans
  • Indoles*
  • Mutation
  • Pyrazoles*
  • Pyridines*
  • Pyrrolidines*
  • Quinolones*

Substances

  • elexacaftor
  • ivacaftor
  • tezacaftor
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • CFTR protein, human
  • Benzodioxoles
  • Indoles
  • Aminophenols
  • Pyrazoles
  • Pyridines
  • Pyrrolidines
  • Quinolones